Blog December 18, 2017
USPTO Requires Registered Practitioners to Create Financial Manager Accounts
- Person title
A Deposit Account is the USPTO's preferred mechanism for customers to pay fees. It eliminates the need to submit a check, credit card or other payment each time a fee is required. Instead, a USPTO deposit account is a pre-paid reserve that a customer can use to pay fees to the USPTO. Until recently, each deposit account was associated with a customer (for example, a law firm or a corporation), and any person associated with the entity (for example, a patent agent, patent attorney) could authorize the USPTO to charge fees to the deposit account associated with the customer.
However, the USPTO has recently made a change to improve security. Effective March 15, any charge to a deposit account may only be made by a person listed in the USPTO's Financial Manager (the USPTO's deposit account management system) as having fee payer permissions. Failure to do so will result in a fee being considered not paid. Financial Manager accounts can be created here. Additional information about the Financial Manager accounts can be found by visiting the Financial Manager website or in a helpful video posted by the USPTO.
Fish's registered practitioners have already created Financial Manager accounts. Clients who have their own deposit accounts will need to add their representative practitioners as authorized users of such deposit accounts.
Prepared with Alycia Morell, Patent Prosecution Training Administrator
The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.
Blog March 22, 2017
Global Dossier — IP5's initiative to increase cross-border patent prosecution efficiency
Blog May 15, 2023
Legal Alert: Minimizing Patent TRO and PI Risk in Europe
Article March 22, 2023
Principals Anita Meiklejohn and Caleb Bates Co-Author Article for One Nucleus Annual Review 2023
Blog March 17, 2023
Legal Alert: The USPTO’s Transition to Electronic Patent Issuance and Reduction in Period Between Issue Notification and Issue Date
Article March 8, 2023
Senior Principal Terry Mahn Authors Medical Device + Diagnostic Industry Article "This Company's False Compliance With CISPR 11 Resulted in a $12 Million FCA...
Article February 17, 2023
Principals Patrick Darno and Peter Fasse Author "Patent Strategies for Protecting Bioinformatics Inventions" for IAM
Article February 3, 2023
Fish & Richardson Attorneys Author IAM Article "Neglect Begets Opportunity in Femtech IP"
Article November 18, 2022
Principal Michael Shepherd Authors Law360 Expert Analysis, "Why PTAB 'Step 2B' Reversal Rates Are Falling"
Article October 20, 2022
Life Sciences Entrepreneur Sourcebook | Intellectual Property: What It Is and Why You Should Care
Article October 12, 2022
Principals Matt Colvin and Betsy Flanagan Author IAM Article "Five Tips to Create a Battle-Ready Portfolio From the Get-Go"
Article September 29, 2022